The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Use of Antidepressants During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in the Offspring
Abstract
OBJECTIVE: Little is known about the impact of in utero exposure to antidepressants on children's long-term mental health. This study analyzed the impact of exposure to antidepressants during pregnancy on the risk of attention-deficit/hyperactivity disorder (ADHD) in the offspring. METHODS: Claims-based data from 38,074 families were used to identify deliveries, parental mental health diagnoses, maternal exposure to antidepressants, and diagnosis or treatment for ADHD in the children. Multiple logistic regressions were performed using the presence of ADHD in the child by the age of 5 years as the dependent variable. RESULTS: A diagnosis of ADHD in the mother or the father was associated with higher rates of ADHD in the children (OR = 4.15, p <.001 and OR = 3.54, p <.001, respectively). A diagnosis of bipolar disorder (OR = 5.08, p <.001), psychotic disorders (OR = 4.05, p =.02), or depressive disorders (OR = 2.58, p <.001) in the mother, but not in the father, increased the risk of ADHD in their children. Exposure to bupropion during pregnancy (OR = 3.63, p =.02), especially during the second trimester (OR = 14.66, p <.001), was strongly associated with increased risk of ADHD, whereas exposure to selective serotonin reuptake inhibitors was not (OR = 0.91, p =.74). CONCLUSION: Children of mothers treated with bupropion during pregnancy have an increased risk of being diagnosed with ADHD; a possible causal effect needs to be further studied. Assessing the mental health of caregivers should be considered as part of the evaluation and treatment of children with ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Third, they indicate that despite a similar pattern of confounding, some risk appears to persist for ADHD, consistent with effects observed in two prior studies, one using claims data, the other a national registry from Denmark12, 13.”
In the citing paper
“Notably, consideration of the first trimester yields adjusted OR >2.0, strongly suggesting that it is the period of greatest risk, although a prior report suggested greatest risk in second trimester12.”
In the citing paper
“Notably, consideration of the first trimester yields adjusted OR >2.0, strongly suggesting that it is the period of greatest risk, although a prior report suggested greatest risk in second trimester12.”
In the citing paper
“given that antidepressant exposure has also been associated with ADHD liability in one cohort12, while a larger one found association with either current or past antidepressant use13.”
In the citing paper
“consistent with a prior investigation of 431 children with ADHD12 which identified association with bupropion exposure.”
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Do multiple outcome measures require p-value adjustment?
Feise, R. J. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-8 · Cited by 1,299
Johnston, C., & Mash, E. J. (2001) · Clinical Child and Family Psychology Review · doi:10.1023/a:1017592030434 · Cited by 1,161
LEVY, F., HAY, D. A., McSTEPHEN, M., WOOD, C., & WALDMAN, I. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00009 · Cited by 956
Van den Bergh, B. R. H., & Marcoen, A. (2004) · Child Development · doi:10.1111/j.1467-8624.2004.00727.x · Cited by 637
Swanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G. A., Volkow, N., Taylor, E., Casey, B. J., Castellanos, F. X., & Wadhwa, P. D. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9019-9 · Cited by 580
CARTER, A. S., GARRITY-ROKOUS, F. E., CHAZAN-COHEN, R., LITTLE, C., & BRIGGS-GOWAN, M. J. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200101000-00012 · Cited by 537
The epidemiology of attention‐deficit/hyperactivity disorder (ADHD): A public health view
Rowland, A. S., Lesesne, C. A., & Abramowitz, A. J. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10036 · Cited by 495
Stahl, S. M., Pradko, J., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0403 · Cited by 495
Yonkers, K. A., Wisner, K. L., Stewart, D. E., Oberlander, T. F., Dell, D. L., Stotland, N., Ramin, S., Chaudron, L., & Lockwood, C. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.04.003 · Cited by 469
Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., & Koren, G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1889 · Cited by 441
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“An estimated 52% of patients with bipolar disorder [43], 60% of patients with MDD [44], and 47% of those with ADHD [45] will have a comorbid anxiety or related disorder.”
BackgroundMcAllister-Williams, R. H., Baldwin, D. S., Cantwell, R., Easter, A., Gilvarry, E., Glover, V., Green, L., Gregoire, A., Howard, L. M., Jones, I., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699361 · Cited by 271
ADHD and autism: differential diagnosis or overlapping traits? A selective review
Taurines, R., Schwenck, C., Westerwald, E., Sachse, M., Siniatchkin, M., & Freitag, C. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0086-2 · Cited by 301
“Disorder-specific risk factors seem to be maternal use of SSRI during pregnancy for ASD (Croen et al. 2011) and bupropion for ADHD (Figueroa 2010).”
Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder
Froehlich, T. E., Anixt, J. S., Loe, I. M., Chirdkiatgumchai, V., Kuan, L., & Gilman, R. C. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0221-3 · Cited by 236
“Like Figueroa [20], prior studies of fetal selective serotonin reuptake inhibitor expoTable 3 Sources of exposure for ADHD environmental risk factors: insufficient exposure associated with increased risk of ADHD”
BackgroundMethodInfluentialClements, C. C., Castro, V. M., Blumenthal, S. R., Rosenfield, H. R., Murphy, S. N., Fava, M., Erb, J. L., Churchill, S. E., Kaimal, A. J., Doyle, A. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.90 · Cited by 197
Recent Trends in Childhood Attention-Deficit/Hyperactivity Disorder
Getahun, D., Jacobsen, S. J., Fassett, M. J., Chen, W., Demissie, K., & Rhoads, G. G. (2013) · JAMA Pediatrics · doi:10.1001/2013.jamapediatrics.401 · Cited by 177
Molenaar, N. M., Bais, B., Lambregtse-van den Berg, M. P., Mulder, C. L., Howell, E. A., Fox, N. S., Rommel, A.-S., Bergink, V., & Kamperman, A. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.12.014 · Cited by 177
“The study by Figueroa (2010), reporting on a cohort from 1997 to 2002, had the lowest prevalence with 2.41%.”
BackgroundInfluentialPicchietti, D. L., Hensley, J. G., Bainbridge, J. L., Lee, K. A., Manconi, M., McGregor, J. A., Silver, R. M., Trenkwalder, C., & Walters, A. S. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.10.009 · Cited by 173
The Use of Central Nervous System Active Drugs During Pregnancy
Källén, B., Borg, N., & Reis, M. (2013) · Pharmaceuticals · doi:10.3390/ph6101221 · Cited by 161
“Another study found that maternal (but not paternal) bipolar disorder, psychotic disorder or depressive disorder increased the risk for ADHD in the child and a strong association with the use of bupropion was found, notably during the second trimester [173].”
BackgroundIn Utero Exposure to Ischemic-Hypoxic Conditions and Attention-Deficit/Hyperactivity Disorder
Getahun, D., Rhoads, G. G., Demissie, K., Lu, S., Quinn, V. P., Fassett, M. J., Wing, D. A., & Jacobsen, S. J. (2012) · PEDIATRICS · doi:10.1542/peds.2012-1298 · Cited by 180
Man, K. K. C., Chan, E. W., Ip, P., Coghill, D., Simonoff, E., Chan, P. K. L., Lau, W. C. Y., Schuemie, M. J., Sturkenboom, M. C. J. M., & Wong, I. C. K. (2017) · BMJ · doi:10.1136/bmj.j2350 · Cited by 135
Morales, D. R., Slattery, J., Evans, S., & Kurz, X. (2018) · BMC Medicine · doi:10.1186/s12916-017-0993-3 · Cited by 118
“Figueroa 2010 [36] Case–control 38,572 431 ICD-9 Marketscan, USA (1997–2006)”
BackgroundGlover, M. E., & Clinton, S. M. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.04.008 · Cited by 116
Suarez, E. A., Bateman, B. T., Hernández–Díaz, S., Straub, L., Wisner, K. L., Gray, K. J., Pennell, P. B., Lester, B. M., McDougle, C. J., Zhu, Y., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.4268 · Cited by 105
Salari, A., Fatehi-Gharehlar, L., Motayagheni, N., & Homberg, J. R. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.062 · Cited by 100
El Marroun, H., White, T., Verhulst, F. C., & Tiemeier, H. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0558-3 · Cited by 92
Liu, X., Agerbo, E., Ingstrup, K. G., Musliner, K., Meltzer-Brody, S., Bergink, V., & Munk-Olsen, T. (2017) · BMJ · doi:10.1136/bmj.j3668 · Cited by 90
Millard, S. J., Weston–Green, K., & Newell, K. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.008 · Cited by 87
“Figueroa (2010) SSRIs, Bupropion, TCA n = 1030 ADD exposed, of which; n = 28 +ADHD n = 3532 children of mothers +MDD, of which; n = 88 +ADHD n = 29, 329 children of mothers –MDD, of which; n = 239 +ADHD 0 – 5 years Significant increase in ADHD in offspring exposed to SSRIs postnatally, and not…”
BackgroundMcDonagh, M. S., Matthews, A. M., Phillipi, C. A., Romm, J., Peterson, K., Thakurta, S., & Guise, J. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000410 · Cited by 92
Robinson, L. R., Bitsko, R. H., O’Masta, B., Holbrook, J. R., Ko, J. Y., Barry, C. M., Maher, B. S., Cerles, A. A., Saadeh, K., MacMillan, L., et al. (2022) · Prevention Science · doi:10.1007/s11121-022-01383-3 · Cited by 85
“00 (Boukhris et al., 2017; Figueroa, 2010); however, only 9 articles were included and did not allow for sub-analyses.”
DNA methylation in neonates born to women receiving psychiatric care
Schroeder, J. W., Smith, A. K., Brennan, P. A., Conneely, K. N., Kilaru, V., Knight, B. T., Newport, D. J., Cubells, J. F., & Stowe, Z. N. (2012) · Epigenetics · doi:10.4161/epi.19551 · Cited by 76
Kaplan, Y. C., Arslan, E. K., Acar, S., & Sözmen, K. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.09.013 · Cited by 69
Homberg, J. R., Kyzar, E. J., Scattoni, M. L., Norton, W., Pittman, J. T., Gaikwad, S., Nguyen, M., Poudel, M. K., Ullmann, J. F. P., Diamond, D. M., et al. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.015 · Cited by 74
Joelsson, P., Chudal, R., Uotila, J., Suominen, A., Sucksdorff, D., Gyllenberg, D., & Sourander, A. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.004 · Cited by 68
Rommel, A., Bergink, V., Liu, X., Munk‐Olsen, T., & Molenaar, N. M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19r12965 · Cited by 72
Prenatal Tdap immunization and risk of maternal and newborn adverse events.
Layton, J. B., Butler, A. M., Li, D., Boggess, K. A., Weber, D. J., McGrath, L. J., & Becker-Dreps, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.071 · Cited by 60
“Where possible, we linked mothers to offspring by identifying newborns within the same insurance plan family grouping with birth coding (ICD-9-CM codes V30-V37) within 7 days of the mother’s delivery code to account for slight differences in billing and enrollment timing between the mother and child [14,20,21]; linkag…”
BackgroundDrug treatment for mood disorders in pregnancy
Gentile, S. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283413451 · Cited by 60
Halmøy, A., Johansson, S., Winge, I., McKinney, J. A., Knappskog, P. M., & Haavik, J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.124 · Cited by 63
Laugesen, K., Olsen, M. S., Telén Andersen, A. B., Frøslev, T., & Toft Sørensen, H. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003507 · Cited by 58
Sujan, A. C., Öberg, A. S., Quinn, P. D., & D'Onofrio, B. M. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13004 · Cited by 58
“note that three of these four studies (Boukhris et al., 2016; Clements et al., 2015; Figueroa, 2010) did not directly compare use during pregnancy to use before pregnancy, and in all four studies the CIs for the association with use before pregnancy overlapped with the CIs for the association with use during pregnancy.”
InfluentialPrenatal and Perinatal Risk Factors
Winiarski, D. A., Hendrix, C. L., Smearman, E., & Brennan, P. A. (2017) · Wiley eBooks · doi:10.1002/9781119092254.ch12 · Cited by 48
The use of antidepressant medication in pregnancy
Ray, S. L., & Stowe, Z. N. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.09.005 · Cited by 47
Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation
Ornoy, A. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2323-z · Cited by 49
“The rate of ADHD at 5 years of age among 114 children born to mothers with depression and prenatally exposed to bupropion, especially during the second trimester of pregnancy, was significantly increased (95).”
Safety of Psychotropic Medications During Pregnancy
Raffi, E. R., Nonacs, R. M., & Cohen, L. S. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.004 · Cited by 45
Hjorth, S., Bromley, R., Ystrøm, E., Lupattelli, A., Spigset, O., & Nordeng, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219778 · Cited by 41
“Figueroa 2010 [56] Anxiolytics ADHD Not mentioned ADHD identified from diagnoses or treatment from practice, not from any formalised test or direct observation.”
BackgroundMethodResultInfluentialPrenatal Antidepressant Exposure: Clinical and Preclinical Findings
Bourke, C. H., Stowe, Z. N., & Owens, M. J. (2014) · Pharmacological Reviews · doi:10.1124/pr.111.005207 · Cited by 44
“Psychiatric disorders exhibit differing degrees of heritability and, as might be predicted, psychiatric disorders in the mother were also positively correlated with attention-deficit hyperactivity disorder risk in the child (Figueroa, 2010).”
BackgroundInfluentialMillard, S. J., Lum, J. S., Fernandez, F., Weston–Green, K., & Newell, K. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118822141 · Cited by 41
Attention-deficit/hyperactivity disorder in pregnancy and the postpartum period
Scoten, O. C., Tabi, K., Paquette, V., Carrion, P. B., Ryan, D. M., Radonjić, N. V., Whitham, E. A., & Hippman, C. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.02.297 · Cited by 41
Studying the Contribution of Serotonin to Neurodevelopmental Disorders. Can This Fly?
Carvajal-Oliveros, A., & Campusano, J. M. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.601449 · Cited by 37
“Similar studies have shown a positive correlation between prenatal SSRI exposure and ADHD (Figueroa, 2010; Clements et al., 2015).”
ResultInfluentialWang, X., Zhang, T., Ekheden, I. G., Chang, Z., Hellner, C., Hasselström, J., Jayaram‐Lindström, N., D'Onofrio, B. M., Larsson, H., Mataix‐Cols, D., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104647 · Cited by 42
“…including ADHD traits rated by mothers using the Conner’s Parent Rating Scale-Revised (Lupattelli et al., 2019), register records of ADHD diagnosis (Figueroa, 2010), oppositional defiant disorder and aggressive behaviour assessed by mothers and teachers using the Child Behaviour Checklist and the…”
InfluentialBoukhris, T., Sheehy, O., & Bérard, A. (2017) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12378 · Cited by 36
Chan, A. Y. L., Gao, L., Howard, L. M., Simonoff, E. A., Coghill, D., Ip, P., Lau, W. C. Y., Taxis, K., Wong, I. C. K., & Man, K. K. C. (2023) · Psychotherapy and Psychosomatics · doi:10.1159/000529141 · Cited by 34
Heilbrun, L. P., Palmer, R. F., Jaén, C. R., Svoboda, M., Perkins, J., & Miller, C. S. (2015) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2015.04.140192 · Cited by 36
“A number of medications used during pregnancy increase the risk of ASD and ADHD.(23,24) Strong evidence supports a causal relationship between ASD and in utero exposure to the medications valproic acid, thalidomide, and misoprostol.”
BackgroundInfluentialSprowles, J. L. N., Wendel, J. R. H., Gutierrez, A., Bailey, R. A., Jablonski, S. A., Williams, M. T., & Vorhees, C. V. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.06.004 · Cited by 35
“Children whose mothers took BUP have increased risk of attention-deficit/hyperactivity disorder (ADHD) (Figueroa, 2010).”
BackgroundOrnoy, A., & Koren, G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201127164000 · Cited by 41
“Figueroa found an increased rate of ADHD among 114 children at 5 years of age that were born to depressed mothers who were given prescriptions for bupropion, especially during the second trimester of pregnancy [68].”
BackgroundExercise and yoga during pregnancy and their impact on depression: a systematic literature review
Jarbou, N. S., & Newell, K. A. (2022) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01189-2 · Cited by 33
“In addition, there is some evidence that perinatal SSRI exposure may increase the risk of neurodevelopmental disorders or associated behaviours for the exposed offspring (Figueroa 2010; Hanley et al.”
BackgroundMan, K. K. C., Chan, E. W., Ip, P., Coghill, D., Simonoff, E., Chan, P. K. L., Lau, W. C. Y., Schuemie, M. J., Sturkenboom, M. C. J. M., & Wong, I. C. K. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.12.007 · Cited by 32
“Evidence from most of the previous studies supports an association between prenatal antidepressant use and the risk of ADHD in children (Boukhris et al., 2017; Clements et al., 2015; Figueroa, 2010; Laugesen et al., 2013; Malm et al., 2016; Man et al., 2017; Sujan et al., 2017).”
BackgroundMethodResultInfluentialAraújo, J. N. D. M., Delgado, I. F., & Paumgartten, F. J. R. (2020) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00026619 · Cited by 43
Halvorsen, A., Hesel, B., Østergaard, S. D., & Danielsen, A. A. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13030 · Cited by 35
“Some studies adjusted for maternal psychotropic medication use during pregnancy (26, 27, 29, 31–37), education (23, 24, 27, 32, 34, 38– 40), socioeconomic status (25, 26, 29, 31, 34, 37, 38, 40, 41), chronic somatic diseases (26, 29, 35, 40), smoking (26, 27, 29, 34–36), parity (23, 24, 26, 27, 29, 34, 35, 37, 39, 41)…”
Should Antidepressants be Avoided in Pregnancy?
Besag, F., & Vasey, M. J. (2022) · Drug Safety · doi:10.1007/s40264-022-01257-1 · Cited by 32
Pharmacotherapy for Perinatal Depression
Lusskin, S. I., Khan, S. J., Ernst, C. L., Habib, S. M., Fersh, M. E., & Albertini, E. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000365 · Cited by 29
Watt, T. T., Appel, L., Lopez, V., Flores, B., & Lawhon, B. (2015) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-015-0102-2 · Cited by 26
“Given the recent and expanding body of research on the risks to infant development of psychotropic medication use in pregnancy [84–86], research should explore the potential of low-risk alternative interventions such as nutrition, exercise, and/or social support for treating depression in pregnancy.”
BackgroundMaternal and paternal psychopathology increases risk of offspring ADHD equally
Lindblad, F., Weitoft, G. R., & Hjern, A. (2011) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796011000564 · Cited by 27
“In a study based on claims on insurance company concerning any indication of ADHD in 431 children ≤5 years of age (Figueroa, 2010), both maternal and paternal ADHD were more common than in comparisons.”
BackgroundResultHealy, D., Noury, J. C. L., & Mangin, D. A. (2016) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-160726 · Cited by 24
Viktorin, A., Levine, S. Z., Altemus, M., Reichenberg, A., & Sandin, S. (2018) · BMJ · doi:10.1136/bmj.k2233 · Cited by 23
Jiang, H., Peng, C., Zhang, X., & Ruan, B. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15059 · Cited by 21
Uğuz, F. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000868 · Cited by 20
Prenatal exposure to antidepressants and risk of epilepsy in childhood
Mao, Y., Pedersen, L. H., Christensen, J., Vestergaard, M., Zhou, W., Olsen, J., & Sun, Y. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4072 · Cited by 19
Zucker, I. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.005 · Cited by 22
“Bupropion (Wellbutrin) Second trimester exposure was associated with ADHD in chilren at 5 years of age or younger (Figueroa, 2010).”
InfluentialWang, Z., Ho, P. W. H., Choy, M. T. H., Wong, I. C. K., Brauer, R., & Man, K. K. C. (2018) · Drug Safety · doi:10.1007/s40264-018-0755-y · Cited by 21
“Of the 111 studies, forty-six (41%) obtained their data from an administrative database/registry (6, 7, 23-30, 32-34, 40, 42, 45-49, 51, 53, 55-57, 61, 62, 69, 71, 72, 77, 82, 83, 85, 88-90, 101, 105, 106, 118, 121, 122, 124, 126, 128), twenty (18%) from an ad hoc disease registry (36, 38, 39, 41, 44, 54, 65, 68, 93,…”
BackgroundResultInfluentialMa, S., Zhu, D., Yin, W., Hao, J., Huang, K., Tao, F., Tao, R., & Zhu, P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.033 · Cited by 19
Williams, S. K., Lauder, J. M., & Johns, J. M. (2011) · Current Neuropharmacology · doi:10.2174/157015911796557957 · Cited by 18
“Prenatal exposure to antidepressants (fluoxetine, paroxetine, sertraline) results in tremulousness, decreased arousal, sleep disturbances and differences in behavioral state regulation in newborns [155], but do not appear to affect mental development, attention, or impulsivity in young children [26,27,156].”
BackgroundPharmacotherapy of mood disorders and psychosis in pre- and post-natal women
Smith, B. A., & Dubovsky, S. L. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1391789 · Cited by 22
“The authors suggested that familial factors seemed more likely than medication exposure to account for risks of ASD and ADHD.”
BackgroundInfluentialYeh, T., Bai, Y., Hsu, J.-W., Huang, K.-L., Tsai, S., Chu, H., Liang, C., & Chen, M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.016 · Cited by 19
Association of maternal depression with children's attention deficit hyperactivity disorder
Sfelinioti, S., & Livaditis, M. (2017) · Psychiatriki · doi:10.22365/jpsych.2017.283.251 · Cited by 15
Prenatal Paternal Selective Serotonin Reuptake Inhibitors Use and Risk of ADHD in Offspring
Yang, F., Liang, H., Chen, J., Miao, M., Yuan, W., Nørgaard, M., & Li, J. (2017) · PEDIATRICS · doi:10.1542/peds.2017-1081 · Cited by 15
Öztürk, B., Ehrenstein, V., Sørensen, H. T., Laugesen, K., & Pedersen, L. H. (2022) · Epidemiology · doi:10.1097/ede.0000000000001494 · Cited by 11
“(7) Drug-class specific analyses: to assess the specificity of the drug-outcome effect, we estimated the effect of different classes of antidepressants: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressant agents (TCAs), or uncategorized antide…”
BackgroundGoracci, A., Valdagno, M., Maltinti, E., Sillari, S., & Fagiolini, A. M. (2015) · Rivista di psichiatria · doi:10.1708/1910.20792 · Cited by 9
Andrade, C., Varadharajan, N., Bascarane, S., & Menon, V. (2024) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13696 · Cited by 8
“Six retrospective cohort studies 10,11,17,20,22,23 (pooled N = 3,915,098) but no case – control study met our search criteria (Figure 1, Table 1, Supplement 3).”
BackgroundMethodInfluentialThe biology of fetal exposure to serotonin reuptake inhibitors: Implications for neurodevelopment
Galbally, M., Lewis, A. J., Gentile, S., Walker, S. P., & Buist, A. (2012) · Murdoch University Research Portal · Cited by 8
Gebelikte Psikotrop İlaç Kullanımı: Bir Güncelleme
Çetin, M. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20110706032759 · Cited by 12
Psychopharmacology in Pregnancy and Postpartum
Robinson, G. E. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.1.3 · Cited by 8
Managing Depression During Pregnancy
Reminick, A. M., Cohen, S., & Einarson, A. (2013) · Women s Health · doi:10.2217/whe.13.58 · Cited by 10
“However, the authors acknowledged that this could not be proven as a causal effect and, in addition, this study was derived from a claims benefit database, which are known to have many limitations [70].”
ResultWisner, K. L., & Schaefer, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408078-2.00012-3 · Cited by 8
Psaros, C., Freeman, M. P., Safren, S. A., Barsky, M., & Cohen, L. S. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000158 · Cited by 10
Molina‐Jiménez, T., Limón‐Morales, O., & Bonilla‐Jaime, H. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.01.004 · Cited by 9
“Some longitudinal and retrospective studies show motor alterations, presence of anxiety, low social and emotional behaviors, higher risk of autism spectrum disorder and attention deficit hyperactivity disorder in children (Boukhris et al., 2016; Figueroa, 2010; Hanley et al., 2015); while in early adolescence increase…”
Hartwig, C. A. M., Robiyanto, R., de Vos, S., Bos, J., van Puijenbroek, E., Hak, E., & Schuiling‐Veninga, C. C. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1000018 · Cited by 8
“…of the dopamine theory of ADHD (Levy, 1991; Swanson et al., 2007) led to an increased interest in evaluating potential associations between drugs and other environmental factors that may influence the dopaminergic system during fetal development and ADHD (Swanson et al., 2007; Figueroa, 2010).”
BackgroundConcepts for selection and utilization of psychiatric medications in pregnancy
Vickery, P. B. (2023) · Mental Health Clinician · doi:10.9740/mhc.2023.12.255 · Cited by 9
“21 – 24 Clinically, bupropion may be considered for depressed women who have failed nonpharmacologic smoking cessation attempts as well as nicotine replacement therapy or who have failed other agents and cannot be switched.”
BackgroundChan, J. K. N., Zhong, A. H. F., Lam, J. Y. H., Wong, C. S. M., Solmi, M., Correll, C. U., & Chang, W. C. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00089-1 · Cited by 6
Fairthorne, J. C., Oberlander, T. F., Brant, R., & Hanley, G. E. (2019) · International Journal for Population Data Science · doi:10.23889/ijpds.v4i1.453 · Cited by 7
“While AD use in the first trimester was associated with a slight increase in preterm births, previously documented associations with infants who were small for gestational age (30) and attentiondeficit/hyperactivity disorder (31) were not present.”
Therapy of peripartum mental disorders
Stanković, M., Stojanov, J., & Antonijević, J. (2018) · AFMN Biomedicine · doi:10.5937/afmnai1904269s · Cited by 6
“The use of bupropion in the first trimester at a daily dose of up to 250 mg increases the risk of ventricular septal defects (29) and hyperkinetic disorder (ADHD) in children (30).”
BackgroundSingh, K. P., Singh, P., Agrawal, P., & Agarwal, B. (2023) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2023.11502 · Cited by 6
“Most clinical studies revealed that infants prenatally exposed to SSRIs are at high risk for developing psychopathology, involving abnormal social behavior and adolescent depression [11-13], but no association with attention-deficit/hyperactivity disorder [14,15].”
BackgroundBromley, R., Wieck, A., MAKAROVA, D., Tower, C. L., WOOD, A. G., & Clayton‐Smith, J. (2012) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539512000095 · Cited by 6
email:, P. (2018) · Drug and Alcohol Review · doi:10.1111/dar.12862 · Cited by 6
Psychopharmaka in Schwangerschaft und Stillzeit
Meisenzahl, E. M. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_16 · Cited by 5
Affektive Störungen in der Schwangerschaft: Therapie mit Antidepressiva und Mood Stabilizern
Bergemann, N., & Paulus, W. E. (2016) · Der Nervenarzt · doi:10.1007/s00115-016-0194-x · Cited by 4
Adult ADHD – diagnosis, causes and outcomes
Kupnicka, Z., Poraj, G., & Kaźmierski, J. (2017) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2017.0023 · Cited by 7
Takahashi, I., Obara, T., Kikuchi, S., Kobayashi, N., Obara, R. D., Noda, A., Ohsawa, M., Ishikawa, T., Mano, N., Nishigori, H., et al. (2024) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.226 · Cited by 3
Psychotropic Medications in Pregnancy and the Postpartum Period
Haas, D. M., McHugh, K. W., Durst, P. J., Rose, S., & Patil, A. S. (2015) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s18902 · Cited by 3
Linking household members and defining relational networks using routine health data
Campbell, J. I., Poblacion, A. P., & Sheward, R. S. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001415 · Cited by 2
Surgical radiofrequency ablation for atrial fibrillation: the Christchurch, New Zealand experience.
Coolbear, F., & Crozier, I. (2011) · PubMed · Cited by 2
Taurines, R., Gerlach, M., & Warnke, A. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_5 · Cited by 3
Taurines, R., Warnke, A., Greenhill, L. L., & Gerlach, M. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_4 · Cited by 2
Öztürk, B., Ehrenstein, V., Nørgaard, M., Sørensen, H. T., & Pedersen, L. H. (2023) · Epidemiology · doi:10.1097/ede.0000000000001615 · Cited by 1
Xin, D., Wang, Y., Hua, G., & Tuo, L. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073278815240325045209 · Cited by 1
Depression in the context of pregnancy
Spinelli, M. G., & Broudy, C. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.015 · Cited by 1
Praxis der Pharmakotherapie der Depression in Schwangerschaft und Stillzeit
Bergemann, N. (2016) · Springer eBooks · doi:10.1007/978-3-662-50347-8_15 · Cited by 3
Grigoriadis, S., & Peer, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_5 · Cited by 3
Spezielle Arzneimitteltherapie in der Schwangerschaft
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-21203-1.10002-0 · Cited by 1
“Citalopram gehört zu den SSRI der 1.”
InfluentialPharmacologic Management of Reproductive Psychopathology
Muzik, M., Shaw, S., Grigoriadis, S., Deligiannidis, K. M., Wieck, A., Chandra, P. S., Murugesan, M., Poland, C. A., & Renn-Bugai, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_143-1 · Cited by 1
Metadata
- Authors
- Figueroa, R.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Figueroa, Roberto
- Venue
- Journal of Developmental & Behavioral Pediatrics
- Published
- 2010-10
- Volume
- 31
- Issue
- 8
- Pages
- 641-648
- ISSN
- 0196-206X (ISSN-L)
- OpenAlex
- W2055099023
- Cited by
- 116
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 2 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 18 · 2016: 11 · 2015: 3 · 2014: 9 · 2013: 9 · 2012: 8
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Developmental & Behavioral Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- attention deficit hyperactivity disorder, maternal mental health, bupropion, selective serotonin reuptake inhibitors, bipolar disorder, depressive disorders, psychosis, prenatal drug exposure
- MeSH terms
- Adult, Attention Deficit Disorder with Hyperactivity, Bipolar Disorder, Child, Preschool, Data Collection, Depressive Disorder, Fathers, Female, Humans, Male, Mothers, Pregnancy, Pregnancy Trimester, Second, Prenatal Exposure Delayed Effects, Psychiatric Status Rating Scales, Psychotic Disorders, Risk Factors, Time Factors, Logistic Models, Child of Impaired Parents, Bupropion, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.